Shares of Aurora Cannabis (NYSE:ACB,TSX:ACB) jumped on Wednesday (March 13) following the appointment of a revered investing figure as a strategic advisor.

Nelson Peltz, founder and CEO of the Trian Fund Management in New York, joined the marijuana company as a strategic advisor, earning himself a chance to become one of the top shareholders in the firm.


Analysts covering the space expect to see a wide variety of suitors for a large established corporation partnership thanks to the hiring.

Aurora holders took in an increase in value of of 13.94 percent and 12.97 percent in New York and Toronto, respectively.

The Canadian firm finished the day with a price of US$9.07 and C$12.02.

Over a year-to-date period shares of the company have increased 51.91 percent in New York.

“We look forward to working with Nelson to further extend our global cannabis industry leadership by aligning Aurora with each of the major market segments cannabis is set to impact,” Terry Booth, CEO of Aurora, said in a press release.

Aurora is giving Peltz the option to purchase over nearly 20 million shares of the company at an adjusted price of C$10.34 per share.

“The Senior Advisor may exercise any portion of the Option that has vested on or prior to the seventh anniversary of the date of grant,” Aurora indicated to shareholders.

Peltz said he sees Aurora as having “strongly differentiated from its peers” and is “poised to go to the next level across a range of industry verticals.”

Aurora’s new hiring added he expects Canadian cannabis producers to lead the charge in the international cannabis market.

The announcement was well received by analysts covering the Canadian cannabis firm, who lauded the vote of confidence by Peltz to the cannabis industry.

Cantech Letter reported Martin Landry, GMP Securities analyst, increased his one-year target price projection on Aurora to C$15. The analyst also upgraded his take on Aurora shares from “Hold” to “Buy.”

“Trian has been involved with a number of CPG companies such as PepsiCo, Dr Pepper Snapple, Procter & Gamble, Kraft Foods, Heinz, Mondelez, among others.

Landry highlighted Trian has worked with large consumer packaged goods (CPG) such as PepsiCo (NASDAQ:PEP), Keurig Dr Pepper (NYSE:KDP) and Procter & Gamble (NYSE:PG).

“We believe he could be instrumental in facilitating discussions with large CPG companies,” Landry wrote in his note to investors.

Vivien Azer, analyst with Cowen covering the cannabis sector, said Peltz gives Aurora a dynamic “network of relationships with large potential strategic companies,” for Aurora to partner with.

“In addition, we think (Aurora) will be more patient in partnership selection than its peers, particularly regarding equity investment,” she said according to a report from MJBiz Daily.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in contributed article. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less